medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2015, Number 2

<< Back Next >>

Ann Hepatol 2015; 14 (2)

Identification of cholesterol gallstone with two-dimensional gel electrophoresis and mass spectrometry

Qian C, Shen Z, Zhang J, Ji F, Liu H

Language: English
References: 30
Page: 251-258
PDF size: 386.99 Kb.


ABSTRACT

Background and rationale. We aimed to provide novel information to better understand the molecular mechanisms underlying gallstones formation and explore the potential protein markers for gallstones progression. The gallbladder tissues were collected from 20 patients with cholesterol gallstone and 10 liver transplant donors from November 2010 to April 2011. The proteomics were compared between gallstone patients and controls by two-dimensional gel electrophoresis (2-DE). The differentially expressed proteins were identified and validated by western blotting and real-time PCR. Results. Total 19 protein spots were found to be different between two groups and 11 proteins were identified, among which 4 ones (such as Peroxiredoxin 3/Prdx3) were down-regulated and 7 (such as Tropomyosin 4/TPM4, Transgelin/SM22, Transthyretin/ TTR) were up-regulated in gallstone group. Results of western blotting and RT-PCR were consistent with the 2-DE results. Conclusion. The differentially expressed proteins of TTR, TPM4, SM22 and Prdx3 may play key roles in gallstone formation and may be markers for gallstone progression.


REFERENCES

  1. Fitzgerald JEF, Fitzgerald LA, Maxwell©Armstrong CA, Brooks AJ. Recurrent gallstone ileus: time to change our surgery? J Digest Dis 2009; 10: 149-51.

  2. Agresta F, Bedin N. Gallstone ileus as a complication of acute cholecystitis. Surgical endoscopy 2003.

  3. Attasaranya S, Fogel EL, Lehman GA. Choledocholithiasis, ascending cholangitis, and gallstone pancreatitis. Medical Clinics of North America 2008; 92: 925-60.

  4. Roizen M, Oz M. Gut Feelings: Your Digestive System. Roizen and Oz; 2005.

  5. Mabee TM, Meyer P, DenBesten L, Mason EE. The mechanism of increased gallstone formation in obese human subjects. Surgery 1976; 79: 460-8.

  6. Tyagi B, Manoharan N, Raina V. Risk factors for gallbladder cancer: A population based case-control study in Delhi. Indian Journal of Medical and Paediatric Oncology 2008; 29: 16.

  7. Johnston DE, Kaplan MM. Pathogenesis and treatment of gallstones. N Eng J Med 1993; 328: 412-21.

  8. Everson GT, McKinley C, Kern Jr F. Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 1991; 87: 237.

  9. Dove A. Proteomics: translating genomics into products? Nat Biotechnol 1999; 17: 233-6. Doi:10.1038/6972.

  10. Banks RE, Dunn MJ, Hochstrasser DF, Sanchez JC, Blackstock W, Pappin DJ, Selby PJ. Proteomics: new perspectives, new biomedical opportunities. Lancet 2000; 356: 1749-56. Doi:S0140-6736(00)03214-1 [pii] 10.1016/S0140- 6736(00)03214-1.

  11. Pandey A, Mann M. Proteomics to study genes and genomes. Nature 2000; 405: 837-46. Doi:10.1038/35015709.

  12. Gygi SP, Corthals GL, Zhang Y, Rochon Y, Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA 2000; 97: 9390-5.

  13. Gorg A, Postel W, Gunther S. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 1988; 9: 531-46.

  14. Hou YF, Yuan ST, Li HC, Wu J, Lu JS, Liu G, Lu LJ, et al. ERbeta exerts multiple stimulative effects on human breast carcinoma cells. Oncogene 2004; 23: 5799-806.

  15. Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ. Nucleation Time: A Key Factor in the Pathogenesis of Cholesterol Gallstone. Gastroenterology 1979; 77: 611-7.

  16. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. The Lancet 2006; 368: 230-9.

  17. Hofmann AF. Bile acids: the good, the bad, and the ugly. News in physiological sciences 1999; 14: 24-9.

  18. Stone B, Gavaler J, Belle S, Shreiner D, Peleman R, Sarva R, Yingvorapant N, et al. Impairment of gallbladder emptying in diabetes mellitus. Gastroenterology 1988; 95: 170-6.

  19. Eisenberg-Grunberg M, Goldgaber DY, Schwarzman AL. Methods for the detection of soluble amyloid β-protein (βAP) or soluble transthyretin (TTR). Google Patents; 1998.

  20. Jacobsson B. In situ localization of transthyretin-mRNA in the adult human liver, choroid plexus and pancreatic islets and in endocrine tumours of the pancreas and gut. Histochemistry 1989; 91: 299-304.

  21. Sundsten T, Östenson CG, Bergsten P. Serum protein patterns in newly diagnosed type 2 diabetes mellitus-influence of diabetic environment and family history of diabetes. Diabetes/metabolism research and reviews 2008; 24: 148-54.

  22. Refai E, Dekki N, Yang SN, Imreh G, Cabrera O, Yu L, Yang G, et al. Transthyretin constitutes a functional component in pancreatic beta-cell stimulus-secretion coupling. Proc Natl Acad Sci USA 2005; 102: 17020-5. Doi:10.1073/ pnas.0503219102.

  23. Sundsten T, Ostenson CG, Bergsten P. Serum protein patterns in newly diagnosed type 2 diabetes mellitus—influence of diabetic environment and family history of diabetes. Diab Metab Res Rev 2008; 24: 148-54. Doi:10.1002/dmrr.789.

  24. Spudich JA, Watt S. The regulation of rabbit skeletal muscle contraction I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin. J Biol Chem 1971; 246: 4866-71.

  25. Kaga E, Karademir B, Baykal AT, Ozer NK. Identification of differentially expressed proteins in atherosclerotic aorta and effect of vitamin E. J Proteomics 2013; 92: 260-73.

  26. Assinder SJ, Stanton J-AL, Prasad PD. Transgelin: an actinbinding protein and tumour suppressor. Int J Biochem Cell Biol 2009; 41: 482-6.

  27. Martín-Rojas T, Gil-Dones F, Lopez-Almodovar LF, Padial LR, Vivanco F, Barderas MG. Proteomic profile of human aortic stenosis: insights into the degenerative process. Journal of proteome research 2012; 11: 1537-50.

  28. Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol 2012; 60: 1854-63.

  29. Hiroi M, Nagahara Y, Miyauchi R, Misaki Y, Goda T, Kasezawa N, Sasaki S, et al. The combination of genetic variations in the PRDX3 gene and dietary fat intake contribute to obesity risk. Obesity (Silver Spring) 2011; 19: 882-7. Doi:10.1038/oby.2010.275.

  30. Long EK, Olson DM, Bernlohr DA. High-fat diet induces changes in adipose tissue trans-4-oxo-2-nonenal and trans-4-hydroxy-2-nonenal levels in a depot-specific manner. Free Radic Biol Med 2013; 63: 390-8. Doi:10.1016/ j.freeradbiomed.2013.05.030.




2020     |     www.medigraphic.com